What is the Procalcitonin (PCT) test?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Procalcitonin (PCT) Test: A Biomarker for Bacterial Infection and Antibiotic Stewardship

The Procalcitonin (PCT) test is a biomarker that helps distinguish bacterial infections from viral or non-infectious causes of inflammation, and guides antibiotic therapy decisions in critically ill patients. It has superior diagnostic accuracy for sepsis compared to other inflammatory markers like C-reactive protein (CRP) 1.

What is Procalcitonin?

Procalcitonin is a precursor protein of calcitonin that can be produced throughout the body. Key characteristics include:

  • Released 3-4 hours after an inflammatory stimulus
  • Peaks within 6-24 hours
  • Half-life of 22-35 hours 2
  • Normal values in healthy individuals: <0.05 ng/mL 1

Clinical Interpretation of PCT Levels

PCT levels correlate with infection severity and decrease rapidly after effective antibiotic treatment 1:

PCT Level Clinical Interpretation
<0.1 ng/mL High probability of viral infection or non-infectious condition
0.1-0.25 ng/mL Low probability of bacterial infection
0.25-0.5 ng/mL Possible bacterial infection
>0.5 ng/mL High probability of bacterial infection
>2.0 ng/mL High probability of sepsis or severe bacterial infection

Diagnostic Accuracy

PCT demonstrates better diagnostic accuracy for sepsis than CRP 2:

  • PCT: Overall area under SROC curve 0.85 (95% CI, 0.82-0.88)

    • Sensitivity: 0.80 (95% CI, 0.69-0.87)
    • Specificity: 0.77 (95% CI, 0.60-0.88)
  • CRP: Overall area under SROC curve 0.73 (95% CI, 0.69-0.77)

    • Sensitivity: 0.80 (95% CI, 0.63-0.90)
    • Specificity: 0.61 (95% CI, 0.50-0.72)

Clinical Applications

When to Use PCT Testing

  • In critically ill patients with new fever and no clear focus of infection when probability of bacterial infection is deemed low to intermediate 2
  • For monitoring response to antibiotic therapy 1
  • For guiding antibiotic discontinuation decisions 3

When NOT to Use PCT Testing

  • To rule out bacterial infection when clinical probability is high 2
  • As the sole determinant for initiating antibiotics in suspected sepsis 2
  • For routine use in all sepsis cases due to cost and availability issues 2

Advantages Over Other Biomarkers

PCT offers several advantages over CRP 1, 4:

  • Earlier rise after infection onset (4 hours vs. 12-24 hours for CRP)
  • More rapid return to normal levels
  • Higher specificity for bacterial infections
  • Less affected by neutropenia, immunodeficiency, and NSAIDs 2

Limitations and Considerations

  • PCT can be elevated during severe viral illnesses, including influenza and COVID-19 1
  • Levels are influenced by renal function and renal replacement therapy 2
  • Should always be interpreted in conjunction with clinical assessment 1
  • Serial measurements showing trends are more valuable than single measurements 1

Antibiotic Stewardship Applications

PCT-guided antibiotic therapy has been shown to:

  • Reduce antibiotic exposure in hospitalized patients 3
  • Improve survival and decrease antibiotic treatment duration in ICU patients 2
  • Support safe antibiotic discontinuation when levels decrease by ≥80% from peak or to <0.25 ng/mL 1

PCT testing represents a valuable tool in the clinician's arsenal for diagnosing bacterial infections and optimizing antibiotic therapy, particularly in critically ill patients, but should always be used as a complement to thorough clinical assessment rather than as a standalone test.

References

Guideline

Sepsis Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Clinical Utility and Measurement of Procalcitonin.

The Clinical biochemist. Reviews, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.